Faculty Information - Hiromichi Yamane

（Last updated : 2024-11-18 16:14:57）

Hiromichi Yamane
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 4,

Position Associate Professor

■ BooK

1.	2016/01	Present issues of cancer survivorship in Japan
2.	2011/09	“Hairy morphology” of hairy cell leukemia-Japanese variant may disappear under specific conditions, BloodMed
3.	2011/07	HHV8- unrelated primary effusion lymphoma- like lymphoma in an elderly man, BloodMed
4.	2011/06	Asian intravascular B-cell lymphoma relapsing in both adrenal glands simultaneously., BloodMed

■ Journal

1.	2011/05	Synchronous double primary lung cancers with different response to pemetrexed.
2.	2011/07	CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab.
3.	2011/07	An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report.
4.	2011/10	Spontaneous regression of pulmonary pure ground-glass opacity with progression of a solid component during a 40-month follow-up
5.	2011/10	Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer.
6.	2011/11	Ovarian inguinal hernia in an elderly female.
7.	2011/11	Variant angina pectoris associated with FOLFOX4 therapy
8.	2011/12	Cavitary pulmonary involvement of diffuse large B-cell lymphoma transformed from extra nodal marginal zone B-cell lymphoma MALT type
9.	2012/02	Ruptured littoral cell angiosarcoma causing hemoperitoneum.
10.	2012/03	Cytotoxicity of Activated Natural Killer Cells and Expression of Adhesion Molecules in Small-cell Lung Cancer
11.	2012/03	Stewart-Treves syndrome after cervical cancer
12.	2012/03	Unusual spontaneous improvement in Asian variant of intravascular large B-cell lymphoma
13.	2012/07	Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
14.	2012/09	Hyaline vascular type Castleman's disease of mesentery
15.	2012/09	Spontaneous expectoration of tumor tissue in a patient with adenocarcinoma of the lung
16.	2012/11	Elevated Coagulation Factor VIII Plasma Activity in a Patient with Lymphangiosarcoma
17.	2013/01	Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
18.	2013/01	Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?
19.	2013/03	Fatal interstitial pneumonia caused by panitumumab containing chemotherapy : a case report
20.	2013/03	Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
21.	2013/04	Continuous pemetrexed treatment for brain metastasis in non-small cell lung cancer-A report of two cases
22.	2013/05	Thickened colon wall in follicular lymphoma
23.	2013/07	Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus associated lymphomatoid granulomatosis
24.	2013/11	Successful treatment of a lung cancer patient with factor XI deficiency
25.	2014/01	Fibrin sheath following pleurodesis
26.	2014/02	Guidelines for Long-Term Steroid Therapy In End-Of-Life Palliative Care
27.	2014/05	Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage.
28.	2014/05	Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.
29.	2014/05	Epiphora in lung cancer patients receiving docetaxel: a case series.
30.	2014/11	Skin involvement in diffuse large B-cell lymphoma detected using positron emission tomography
31.	2014/10	Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma.
32.	2015/01	Cisplatin-induced hyponatremia in malignancy:comparison between brand-name and generic formulation
33.	2015/04	Non-occlusive mesenteric ischemia after splenic metastasectomy for small-cell lung cancer
34.	2015/06	Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
35.	2015/06	Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines
36.	2015/09	Successful palliation for an aged patient with primary pericardial mesothelioma
37.	2015/10	Progressive paraplegia caused by recurrence of mantle cell lymphoma with atypical spinal magnetic resonance imaging features
38.	2015/11	PET superscan caused by lung cancer
39.	2016/02	Dropped head syndrome following mantle radiation therapy
40.	2016/11	Gynecomastia as a paraneoplastic symptom of choriocarcinoma
41.	2016/11	High uptake of Fluorodeoxy glucose along biliary stent
42.	2017/09	Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: A multicenter phase II trial of West-JHOG PTCL0707.
43.	2018/02	Patients with osteosarcoma and soft tissue sarcoma might become"cancer refugee" in some Japanese regional cities
44.	2018/07	"Engagement ring" image conveys regrettable outcome for aged patients with non-small cell lung cancer.
45.	2018/08	Erythema as a Visual Surrogate Marker of Glucagonoma
46.	2018/08	Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: A comparison of serum Krebs von Lungen-6 and Thymus and Activation-Regulated Chemokine/CC Chemokine Ligand 17
47.	2018/08	Histology versus cytology: PD-L1 testing in non-small cell lung cancer
48.	2018/11	Publication of lung cancer clinical trials in the Japanese Clinical Trial Registry.
49.	2018/10	Acute necrotizing encephalopathy in an adult with influenza A infection.
50.	2024/11/16	Four cases with FUS/CHOP fusion gene products positive myxoid liposarcoma responding effectively to trabectedin monotherapy
51.	2024/10	A case of primary duodenal Brunner's gland hamartoma that gradually underwent morphological changes over a period of ten years
52.	2024/07/19	The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells
53.	2023/09	Clinical features of patients with hematological malignancies treated at the palliative care unit
54.	2022/03/31	Herpes zoster in lung cancer patients treated with PD-1/PD-L1 inhibitors
55.	2021/12	Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells
56.	2021/06/03	IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
57.	2021/04/03	Lung cancer metastasis to the pancreas mimicking autoimmune pancreatitis
58.	2020/07	Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
59.	2020/01	Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.
60.	2018/10	Descending necrotizing mediastinitis in a healthy young adult.
61.	2018/01	Accidental aspiration of denture cleanser tablets caused severemucosal edema in upper airway.
62.	2017/12	Ceftriaxone-associated pancreatitis captured on serial computed tomography scans.
63.	2017/12	Effects of (-)-epigallocatechin-3-gallate on EGFR- or fusion gene-driven lung cancer cells.
64.	2016/06	Herpetic esophagitis following bendamustine-containing regimen
Display 5 items
Display all(64)

■ Presentation

1.	2014/04/27	Circulating TARC/CCL17 is a possible diagnostic marker for interstitial lung disease (ILD) in patients with non-small cell lung cancer (NSCLC) （Poster notice，General）
2.	2022/02/17	Long-term response to alectinib in a patient with ALK-fusion genemerged in afatinib-resistant EGFR mutated lung cancer （Poster notice，General）
3.	2021/10/21	非高齢者進⾏肺癌に対する免疫チェックポイント阻害薬投与と帯状疱疹発症の検討（Speech，General）
4.	2018/07/20	Patients with osteosarcoma and soft tissue sarcoma tend to become cancer refugees in Japanese regional cities （Poster notice）
5.	2016/04/20	Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer （Poster notice）
6.	2015/10/08	Two Newly Discovered Mechanisms of Acquired Resistance to the Selective ALK Inhibitor Alectinib in Lung Cancer （Speech，General）
7.	2015/04/20	Both Programmed cell death protein 1 and programmed death-ligand 1 molecules can be expressed on the surface of small-cell lung cancer （Poster notice，General）
8.	2014/09/28	Acquired resistance to a new ALK inhibitor, alectinib in lung cancer （Poster notice，General）
Display 5 items
Display all(8)